Telomir Pharmaceuticals, Inc. (TELO) Insider Trading

Name: Telomir Pharmaceuticals, Inc. (TELO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 27, 2026): Whalen Matthew Pratt (Director): Grant/Award of 50,000 shares.

Get alerted when insiders trade TELO

Email address

Loading company data...

Loading company details...